 "remdesivir, coronavirus, drugs, covid, pharma")
Pharma major Cadila Healthcare (Zydus Cadila) on Thursday announced launch of what is so far India's cheapest remdesivir brand - Remdac at Rs 2800 per 100 mg lyophilized injection vial.
The will be made available across India through the group’s strong distribution chain reaching out to government and private hospitals treating Covid patients.
According to Sharvil Patel, managing director of Cadila Healthcare, as the most affordable remdesivir brand, Remdac will enable patients ot have access to the critical drug in treatment of Covid-19.
"Through the course of this pandemic, our efforts have been focussed on supporting people in this healthcare
